Naoya Inoue seeks new foe with Sam Goodman out for Dec. 24 bout

Naoya Inoue seeks new foe with Sam Goodman out for Dec. 24 bout 1 | ASL

Sam Goodman suffered a serious cut over his eye and won’t be available to challenge undisputed junior featherweight champion Naoya Inoue on Dec. 24 in , officials told ESPN on Friday night.

‘s Goodman, the mandatory challenger, was pictured with a gash over his left eye in a social media post from Fox Sports Australia. According to the post, Goodman’s team is seeking a delay for the fight.

However, Inoue will fight a replacement opponent on Christmas Eve if a suitable replacement opponent can be secured on 10 days’ notice, officials said.

A major star in , Inoue (28-0, 25 KOs) sold out the Tokyo Dome in May when he knocked out Luis Nery with 50,000-plus in attendance. In September, Inoue retained his four 122-pound belts with a seventh-round TKO of TJ Doheny, who is also from Australia.

The Inoue-Goodman fight was set to be streamed on ESPN+ on Christmas Eve morning in the U.S.

Inoue, ESPN’s No. 3 pound-for-pound boxer, was a -2000 favorite to defeat Goodman, according to ESPN BET. Inoue is already an all-time great, a four-division champion who has dominated every weight class he has reigned in.

Goodman (19-0, 8 KOs), 25, is ESPN’s No. 4 junior featherweight and has proved his mettle in wins over fellow contenders Ra’eese Aleem and Doheny. He is coming off a July decision win over Thai fringe contender Thachtana Luangphon.

Should he find a replacement opponent, Inoue would be taking part in his third fight of the year and the third defense of his undisputed championship and would fulfill another mandatory obligation. The 31-year-old will still owe a mandatory defense afterward against Uzbekistan’s Murdjon Akhmadaliev.

Inoue, a future Hall of Famer, hasn’t competed in the U.S. since June 2021, but there are plans for him to return for a stateside fight in 2025.

Source: espn.com

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More